Indoco Warren Lignox Lignocaine 2% (Pack Of 24)
Warren Lignox Lignocaine 2% A is a specialized local anesthetic solution designed to alleviate pain and induce sedation during dental surgical, endodontic, and operative procedures. It is delivered using nerve block or infiltration methods, ensuring precise and localized pain management.
This formulation contains two crucial elements: adrenaline and lignocaine. Adrenaline, at a concentration of 1:80000 MG, acts as a vasoconstrictor, reducing blood flow to the surgical area and improving visibility by minimizing bleeding. Additionally, this vasoconstrictive property extends the duration of the anesthetic, boosting its efficacy.
Lignocaine, present at 2% w/v, is the primary anesthetic agent in Warren Lignox. It functions by stabilizing the neuronal membrane, impeding the ionic movements necessary for nerve impulse initiation and conduction. This mechanism blocks pain signal transmission from the administration site, delivering pain relief to the patient.
Key Components:
- Adrenaline (1:80000 MG):
- Acts as a vasoconstrictor, reducing blood flow to the surgical site.
- Diminishes bleeding, enhancing visibility during the procedure.
- Contributes to prolonged anesthetic action, improving effectiveness.
- Lignocaine (2% w/v):
- Primary anesthetic agent in Warren Lignox.
- Stabilizes neuronal membranes, inhibiting necessary ionic fluxes for nerve impulse initiation and conduction.
- Blocks the transmission of pain signals, providing efficient pain relief.
Indications:
- Warren Lignox is specifically formulated for use in surgical, endodontic, and operative dental procedures.
- Administered through nerve block or infiltration techniques.
Features :
- Dose: Maximum recommended dose - 4.4 mg/kg, adjusted based on body size, age, and dental procedure.
- Cartridge: Contains 1.8 ml with adrenaline concentration of 0.023 mg.
- Volume: Warren Lignox Lignocaine 2% A - up to 2.3 ml.
- Active Ingredients: Adrenaline (epinephrine) acid tartrate and Lidocaine (lignocaine) hydrochloride.
- Onset: 2-3 minutes.
- Prolonged Effect: Contains adrenaline to extend duration of action.
- Vasoconstriction: Adrenaline narrows blood vessels, reducing bleeding and improving visibility during dental work.
Specifications :
Pharmacodynamic properties- Pharmacotherapeutic group: Anaesthetics, Amides .
Pharmacokinetic properties - The concentration of Lidocaine in the blood will be determined by its rate of absorption from the site of injection, the rate of tissue distribution and the rate of metabolism and excretion.
Shelf Life - Validity Till 2020 . If only part of an ampoule is used, the remainder should be discarded.
Storage temperature - 2°C to 8°C (Refrigerate. Do not freeze) and it is protected from light. Once removed from refrigeration for use, it will be stored below 25°C and used within 4 weeks and not returned to the refrigerator.
Special precautions for disposal and other handling.
1) For I.M. injection.
2) Use as directed by the Dental Surgeons.
3) Keep out of reach of children.
4) If only part used, discard the remaining solution.
Pharmaceutical form
1) Solution for Injection.
2) Clear and colorless solution.
Local Anesthetic - 30ml vial.
- Anesthetic Half Life - 1.5 to 2 hours .
PRECAUTIONS -
- Keep this medicine out of the sight and reach of children.
- Do not store above 25ºC.
- Do not use this medicine after the expiry date which is stated on the ampoule/vial and carton.
- The expiry date refers to the last day of that month.
- Discard any unused contents.
- The product should be used immediately after opening.
- The injection should not be used if there are particles present.
Packaging :
- 24 x 30ml Lignox Vials 2%
Direction To Use :
- Use a dental syringe for the injection of Warren Lignox Lignocaine 2% A .
- It consists of a breech-loading syringe fitted with a sealed cartridge.
- Now load the Syninge with Warren Lignox Lignocaine 2% A
- Then Inject the needle and deposit Warren Lignox Lignocaine close to the peripheral nerve or network of nerves.
- Wait for 10-15 minutes until it anesthetizes the Nerve.
- This will result in an area of numbness at the site or near the site of injection.
- Do not reuse needles, syringes, or other materials.
WARNING-
- If a patient is suffering from unstable angina or severe cardiac dysrhythmia, these preparations are often discouraged as they may predispose to unfavorable side effects. This is particularly done when alcoholism, anemia, anorexia, bradycardia or GORD is concerned.
- On other occasions the vasoconstrictor used (often adrenaline) must be reduced when an individual suffers from angina, bradycardia, chronic bronchitis, cardia disarrhythmia, COPD or glaucoma.
- If the patient is allergic (hypersensitive) to any of the ingredients in this injection, suffering from any form of heart disease, suffering from brain damage or hardening of the arteries in the brain, suffering from glaucoma (increased pressure in the eye), having or in the second stage of labor.
- Take special care if you are: suffering from high blood pressure, pregnant or breastfeeding, or diabetic.
